Alpha-Lipoic Acid for Burning Mouth: Four Trial Checks

Who finished?

The Spanish trial enrolled 60 people with burning mouth syndrome; 54 finished two months: 25 taking alpha-lipoic acid and 29 taking placebo. The six losses are unexplained. Fifty-five of those enrolled were women. Allocation concealment and handling of missing results are not described.¹

What counted?

Sixteen of 25 active-treatment completers improved, versus eight of 29 controls. Improvement pooled slight improvement, greater improvement and resolution; these are not cure rates. Sesderma supplied active capsules and placebo; authors declared no conflicts.¹

Did relief last?

Five of the 16 active-treatment responders worsened one month after treatment ended. The reported maintenance percentage describes responders, not everyone who entered. Longer-lasting benefit remains uncertain.¹

What needs review?

A burning mouth needs an assessment before a supplement experiment. NIDCR² advises a medical history and mouth examination to rule out other causes, including tooth or gum problems, infection and irritation. Depending on the findings, clinicians may use blood tests, oral swabs, allergy tests or saliva-flow tests. A deficiency, dry mouth or a medicine may require a different approach. Ask which causes have been checked and what the next treatment is intended to change.²

US dietary supplements are not FDA³-approved for safety and effectiveness before sale. A bottle on a shelf does not establish that its contents treat burning mouth syndrome. FDA advises reviewing supplements with a healthcare professional because they can interact with medicines or affect laboratory tests. Bring the exact product label and your medicine list; do not substitute a supplement for a prescribed treatment.³

A 2016 Health Canada⁴ safety review linked alpha-lipoic acid to rare insulin autoimmune syndrome, which can cause low blood sugar in genetically susceptible people. It advises stopping the product and consulting a healthcare professional if symptoms such as sweating, paleness, chills, headache, dizziness or confusion occur. This Canadian review identifies a potential harm; it does not establish a burning-mouth benefit or the frequency of that harm in these trial participants.⁴

Is It My Breath? discusses burning mouth in “Menopause and the Mouth,” including the need to investigate other causes and the limits of treatment evidence. Bring a record of burning severity, eating or speaking difficulties and treatment changes to your review, so symptom relief and unwanted effects can be considered together.